about
The P42 peptide and Peptide-based therapies for Huntington's diseaseApplications and Challenges for Use of Cell-Penetrating Peptides as Delivery Vectors for Peptide and Protein CargosStructure analysis and conformational transitions of the cell penetrating peptide transportan 10 in the membrane-bound state.Systemic delivery of P42 peptide: a new weapon to fight Huntington's disease.Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.Methods for the creation of cyclic Peptide libraries for use in lead discovery.Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier.Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation.Tackling amyloidogenesis in Alzheimer's disease with A2V variants of Amyloid-β.Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Approaches for enhancing oral bioavailability of peptides and proteinsStrategies for non-invasive delivery of biologics.Peptide pills for brain diseases? Reality and future perspectives.Oral delivery of therapeutic proteins and peptides: a review on recent developments.Basics and recent advances in peptide and protein drug delivery.Harnessing proteasome dynamics and allostery in drug design.Biologics: the role of delivery systems in improved therapy.Formulation strategies to improve oral peptide delivery.Advances in oral macromolecular drug delivery.Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis.Strategies to stabilize cell penetrating peptides for in vivo applications.Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals.Peptide nanostructures in biomedical technology.Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.A BODIPY-embedding miltefosine analog linked to cell-penetrating Tat(48-60) peptide favors intracellular delivery and visualization of the antiparasitic drug.Spontaneous membrane-translocating peptide adsorption at silica surfaces: a molecular dynamics study.Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal MembraneThe potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders.Translational Research in Alzheimer's and Prion Diseases.Strategies and industrial perspectives to improve oral absorption of biological macromolecules.Enantiomeric and diastereoisomeric (mixed) L/ D-octaarginine derivatives - a simple way of modulating the properties of cell-penetrating peptides.Oral insulin delivery: existing barriers and current counter-strategies.The function of activatable cell-penetrating peptides in human intrahepatic bile duct epithelial cells.MSN-mediated sequential vascular-to-cell nuclear-targeted drug delivery for efficient tumor regression.The Current Role of Cell-Penetrating Peptides in Cancer Therapy.Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: preparation and evaluation.Peptides as drug delivery vehicles across biological barriersNatural and Synthetic Polymers as Drug Carriers for Delivery of Therapeutic ProteinsThiolation and Cell-Penetrating Peptide Surface Functionalization of Porous Silicon Nanoparticles for Oral Delivery of Insulin
P2860
Q26764930-991AE650-CDDA-485B-876D-18C0AB6CF824Q26769800-519EA124-1B7C-49F1-B344-8987590BD399Q33769108-86F4D042-F1FF-4332-AE3A-78C1FCF2A965Q34109060-EA3FA3CB-193B-4406-B331-42427A994FB1Q35031451-747D7F28-9588-479B-9F21-4B3F61B2B545Q35542409-B4D108BC-1A4E-42CC-8D46-768221074458Q35785197-A10A2E22-7BF5-48A7-A21D-AD47F0C6C76EQ35967870-60243821-EFB5-48EF-AC23-3312CFF67BC7Q36569888-53697A23-DE84-4F86-9CD6-5E20C8C8BF98Q36640081-F0E6943A-3667-4268-8228-55197C38D8D9Q36922557-8AD2E23E-040A-4340-B23F-F156891C150FQ38013190-80A5AFB3-68C2-4D30-986F-41F6B5B210ADQ38096036-C43E9DEF-3D8F-45A4-9C36-562A8F594949Q38122734-A9B6FFA8-3240-4BF3-BD08-130489D3EFDFQ38162494-E4D98679-226D-46E8-9DE4-FAAE1AB012D6Q38177328-5B157E2A-3064-4073-97A3-4087D80C02D0Q38199664-F2BCD17D-6926-4252-95A8-921EEC6678E5Q38226675-E4B14B23-128F-4E5B-8CCC-6222AF65BC01Q38235506-0632F778-4B25-441C-BCA9-2CE998FE8080Q38266101-F471BFB5-246E-4A64-8AE2-7E08CF51C4EAQ38602460-FB702F84-92CE-4E65-B153-CF9B076D604CQ38622635-35E929E8-94E7-4820-B884-8035FFE1039DQ38723306-1678B2E6-3502-45F1-AEA8-B067269B62ECQ38881439-059DC9B4-CDD4-4516-ADD5-A3A86812E7B2Q38932275-91FE06F2-E141-474A-AA0F-D3BF963665CBQ39032576-CFC2C98C-3CCA-4026-A49F-FB4FC7C0FDE2Q39323442-3F8F4801-78AC-4427-80C2-03401BD26750Q40689786-58DCC4A2-0574-49BE-B6A4-2F2E198BE452Q42253045-74029CEA-ECA4-41BD-89BB-4ACD74692CB6Q47368173-DE3FB564-5A03-459D-9C30-4D8568F4336FQ47431381-58D87624-776D-4318-AB2D-0D30FD3673E7Q48021428-77CB0048-38A4-4751-BD62-405D58B9DE8DQ48203947-2C78F5B4-2200-4B8F-A7CB-29E66CD391F0Q51042421-6D4BB5E6-021C-4E49-A224-7267D71764FCQ51060665-2CDD5DCE-F5A1-4DCB-B8E5-36625CA2AE44Q52450404-0252767E-236B-44E7-BAE1-45BE0683F213Q52613779-E5325758-5FD9-45D4-B1DE-1456E73CC0D3Q56889662-388520EE-DFAD-4135-8FBA-25165B073CB5Q57369611-9C8D9BE4-18AA-4436-A3FD-9FF37B8168ADQ57570714-E17EDBF3-43B0-410F-92A7-A51A956BAC14
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Oral biodrug delivery using cell-penetrating peptide.
@en
Oral biodrug delivery using cell-penetrating peptide.
@nl
type
label
Oral biodrug delivery using cell-penetrating peptide.
@en
Oral biodrug delivery using cell-penetrating peptide.
@nl
prefLabel
Oral biodrug delivery using cell-penetrating peptide.
@en
Oral biodrug delivery using cell-penetrating peptide.
@nl
P1476
Oral biodrug delivery using cell-penetrating peptide.
@en
P2093
El-Sayed Khafagy
Mariko Morishita
P304
P356
10.1016/J.ADDR.2011.12.014
P407
P577
2012-01-04T00:00:00Z